# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Ongoing efforts to build a robust global patent estate for a growing pipeline targeting high-value indications in need of innov...
Company advancing an innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune dise...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.